A detailed history of Eisler Capital (Uk) Ltd. transactions in Axonics, Inc. stock. As of the latest transaction made, Eisler Capital (Uk) Ltd. holds 98,470 shares of AXNX stock, worth $6.99 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
98,470
Holding current value
$6.99 Million
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.3 - $69.67 $6.63 Million - $6.86 Million
98,470 New
98,470 $6.86 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Eisler Capital (Uk) Ltd. Portfolio

Follow Eisler Capital (Uk) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.